Cutting Edge: Expression of Functional CD137 Receptor by Dendritic Cells
Ryan A. Wilcox(University of Michigan), Lieping Chen(Yale Cancer Center), Tahiro Shin(Johns Hopkins University), Robert S. Mittler(Ortho Clinical Diagnostics (United States)), Mizuto Otsuji(Johns Hopkins University), Dallas B. Flies(Mayo Clinic in Arizona), Drew M. Pardoll(Bloomberg (United States)), Haruo Tsuchiya(Johns Hopkins University), Andrei I. Chapoval(Human Genome Sciences (United States)), Kevin Gorski(Amgen (United States)), Koji Tamada(Yamaguchi University)
Cited by 231
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k